Idiomas      
   

Página Inicial
principais dúvidas
epidemiologia
patogeniese
diagnóstico
tratamento
prevenção
conheça mais sobre os autores
conheça mais sobre os autores
conheça mais sobre os autores
Download de artigos relacionados

Patogênese

Acknowledgments

We thank Dana Gallo for a critical revision of this manuscript.

References

1. Aboulafia DM (1995). Clinical implications of human T-cell leukemia virus type I/II-associated diseases. AIDS Reader, 5: 118-125.
2. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K & Uchino H (1977). Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood, 50: 481-492.
3. Osame M, Janssen R, Kubota H, Nishitani H, Igata A, Nagataki S, Mori M, Goto I, Shimabukuro H & Khabbaz R (1990). Nationwide survey of HTLV-I-associated myelopathy in Japan: association with blood transfusion. Annals of Neurology, 28: 50-56.
4. Gessain A, Barin F, Vernant JC, Gout O, Maurs L, Calender A & de The G (1985). Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet, 2: 407-410.
5. Osame M, Usuku J, Izumo S, Ijichi N, Amitani H, Igata A, Matsumoto M & Tara M (1985). HTLV-I-associated myelopathy: a new clinical entity. Lancet, 1: 1031-1032.
6. Gessain A & Gout O (1992). Chronic myelopathy with human T-lymphotropic virus type I (HTLV-I). Annals of Internal Medicine, 117: 933-946.
7. Iwasaki Y (1990). Pathology of chronic myelopathy associated with HTLV-I infection (TSP/HAM). Journal of Neurological Sciences, 96: 103-123.
8. Seiki M, Hattori S, Hirayama Y & Yoshida M (1983). Human adult T-cell leukemia virus: complete nucleotide sequence of the provirus genome integrated in leukemia cell DNA. Proceedings of the National Academy of Sciences, USA, 80: 3618-3622.
9. Murphy EL & Blattner WA (1988). HTLV-I-associated leukemia: a model for chronic retroviral diseases. Annals of Neurology, 23: S174-S180.
10. Piccardo P, Ceroni M, Rodgers-Johnson P, Mora C, Asher DM, Char G, Gibbs Jr CJ & Gajdusek DC (1988). Pathological and immunological observations on tropical spastic paraparesis in patients from Jamaica. Annals of Neurology, 23: 156-160.
11. Azizuki S, Nakasato O, Higuchi Y, Tanabe K, Setoguchi M, Yoshida S, Miyazaki Y, Yamamoto S, Sudou S, Sannomiya K & Okajima T (1987). Necropsy findings in HTLV-I associated myelopathy [Letter]. Lancet, 1: 156-157.
12. Tendler GL, Greenberg SJ, Blattner WA, Manns A, Murphy E, Fleisher T, Hanchard B, Morgan O, Burton JD, Nelson DL & Waldmann TA (1990). Transactivation of interleukin 2 and its receptor induces immune activation in human T-cell lymphotropic virus type I-associated myelopathy: Pathogenic implications and a rationale for immunotherapy. Proceedings of the National Academy of Sciences, USA, 87: 5218-5122.
13. Cheng H, Tranok J & Parks WP (1998). Human immunodeficiency virus type 1 genome activation induced by human T-cell leukemia virus type 1 tax protein is through cooperation of NF-kB and tat. Journal of Virology, 72: 6911-6916.
14. Gessain A, Saal F, Gout O, Daniel MT, Flandrin G, de The G, Peries J & Sigaux F (1990). High human T-cell lymphotropic virus type I proviral DNA load with polyclonal integration in peripheral blood mononuclear cells of French West Indian, Guianese, and African patients with tropical spastic paraparesis. Blood, 75: 428-433.
15. Nagai M, Usuku K, Matsumoto W, Kodama D, Takenouchi TM, Hashiguchi S, Ichinose M, Bangham C, Izumo S & Osame M (1998). Analysis of HTLV-I proviral load in 202 TSP/HAM patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to TSP/HAM. Journal of Neurovirology, 4: 586-593.
16. Manns A, Miley JW, Wilks JR, Morgan OC, Hanchard B, Warfe G, Cranston B, Maloney E, Welles LS, Blattner AW & Waters D (1999). Quantative proviral DNA and antibody levels in the natural history of HTLV-I infection. Journal of Infectious Diseases, 180: 1487-1493.
17. Hara H (1994). Autoimmune mechanism in TSP/HAM. Nippon Rinsho, 52: 2919-2925.
18. Levin MC, Krichavsky M, Berk J, Foley S, Rosenfeld M, Dalmau J, Chang G, Posner JB & Jacobson S (1998). Neuronal molecular mimicry in immune-mediated neurologic disease. Annals of Neurology, 44: 87-98.
19. Hoffman TL & Doms RW (1998). Chemokines and coreceptors in HIV/SIV-host interactions. AIDS, 12 (Suppl A): S17-S26.
20. Copeland KFT & Heeney JL (1996). T helper cell activation and human retroviral pathogenesis. Microbiological Reviews, 60: 722-742.


<< Anterior
Págs.    1   |  2  |  3  |  4  |  5  |  6  |  7  |  8

 

Produzido por Exfera Produtora web e Multimidia